Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Acquired Diseases
  • Published:

Local administration of transcription factor decoy oligonucleotides to nuclear factor-κB prevents carrageenin-induced inflammation in rat hind paw

Abstract

The transcription factor nuclear factor-κB (NF-κB) plays a key role in the expression of several genes involved in the inflammatory process. In the present study we investigated in an acute model of inflammation, the carrageenin-induced hind paw edema, the anti-inflammatory effect of double stranded oligodeoxynucleotides (ODN) with consensus nuclear factor-κB (NF-κB) sequence as transcription factor decoys (TFD) to inhibit NF-κB binding to native DNA sites. Local administration of wild-type, but not mutant-ODN decoy, dose-dependently inhibited edema formation induced by carrageenin in rat paw. Molecular analysis performed on soft tissue obtained from inflamed paw demonstrated: (1) an inhibition of NF-κB DNA binding activity; (2) a decreased nuclear level of p50 and p65 NF-κB subunits; (3) an inhibition of cyclooxygenase-2 (COX-2) and inducible nitric oxide synthase (iNOS) protein expression, two inflammatory enzymes transcriptionally controlled by NF-κB. Furthermore, SN-50, a cell-permeable peptide capable of inhibiting the nuclear translocation of NF-κB complexes, exhibited a similar profile of activity of ODN decoy. Our results indicate for the first time that ODN decoy, acting as an in vivo competitor for the transcription factor's ability to bind to cognate recognition sequence, may represent a novel strategy to modulate acute inflammation.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4
Figure 5
Figure 6
Figure 7

Similar content being viewed by others

References

  1. Movat HZ . Mediators of the vascular phenomena of acute inflammation. In: Movat HZ (ed) The Inflammatory Reaction Elsevier: Amsterdam 1985 77–86

    Google Scholar 

  2. Di Rosa M, Giroud JP, Willoughby DA . Studies of mediators of the acute inflammatory response induced in rats in different sites by carrageenin and turpentine J Pathol 1971 104: 15–29

    Article  CAS  PubMed  Google Scholar 

  3. Ialenti A, Ianaro A, Moncada S, Di Rosa M . Modulation of acute inflammation by endogenous nitric oxide Eur J Pharmacol 1992 211: 177–182

    Article  CAS  PubMed  Google Scholar 

  4. Salvemini D et al. Nitric oxide: a key mediator in the early and late phase of carrageenan-induced rat paw inflammation Br J Pharmacol 1996 118: 829–838

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  5. Seibert K et al. Pharmacological and biochemical demonstration of the role of cyclooxygenase 2 in inflammation and pain Proc Natl Acad Sci U S A 1994 91: 12013–12017

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  6. Salvemini D et al. Dual inhibition of nitric oxide and prostaglandin production contributes to the anti-inflammatory properties of nitric oxide synthase inhibitors J Clin Invest 1995 96: 301–308

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  7. Tomlison A et al. Cyclo-oxygenase and nitric oxide synthase isoforms in rat carrageenan-induced pleurisy Br J Pharmacol 1994 113: 693–698

    Article  Google Scholar 

  8. Ialenti A, Moncada S, Di Rosa M . Modulation of adjuvant arthritis by endogenous nitric oxide Br J Pharmacol 1993 110: 701–706

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  9. Ianaro A, Ialenti A, Sautebin L, Di Rosa M . Nitric oxide inhibits neutrophil infiltration in the reverse passive Arthus reaction in rat skin N-S Arch Pharmacol 1998 358: 489–495

    Article  CAS  Google Scholar 

  10. Iuvone T et al. Differential effect of L-NAME and S-methyl-isothiourea on leukocyte emigration in carrageenin-soaked sponge implants in rat Br J Pharmacol 1997 121: 1637–1644

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  11. Iuvone T et al. Evidence that inducible nitric oxide synthase is involved in LPS-induced plasma leakage in rat skin through the activation of nuclear factor-κB Br J Pharmacol 1998 123: 1325–1330

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  12. Fletcher BS, Kujubu DA, Perrin DM, Herschman HR . Structure of the mitogen-inducible TIS10 gene and demonstration that the TIS10-encoded protein is a functional prostaglandin G/H synthase J Biol Chem 1992 267: 4338–4344

    CAS  PubMed  Google Scholar 

  13. Sirois J, Levy LO, Simmons DL, Richards JS . Characterisation and hormonal regulation of the promoter of rat prostaglandin endoperoxide synyhase 2 gene in granulosa dells. Identification of functional and protein-binding regions J Biol Chem 1993 268: 12199–12206

    CAS  PubMed  Google Scholar 

  14. Kosaka T et al. Characterisation of the human gene (PTGS2) encoding prostaglandin-endoperoxide synthase 2 Eur J Biochem 1994 221: 889–897

    Article  CAS  PubMed  Google Scholar 

  15. Xie QW, Whisnant R, Nathan C . Promoter of the mouse gene encoding calcium-independent nitric oxide synthase confers inducibility by interferon γ and bacterial lipopolysaccharide J Exp Med 1993 177: 1779–1784

    Article  CAS  PubMed  Google Scholar 

  16. Lowenstain CJ et al. Macrophage nitric oxide synthase gene: two upstream regions mediate induction by interferon γ and lipopolysaccharide Proc Natl Acad Sci USA 1993 90: 9730–9734

    Article  Google Scholar 

  17. De Vera ME et al. Transcriptional regulation of human inducible nitric oxide synthase (NOS2) gene by cytokines: initial analysis of the human NOS2 promoter Proc Natl Acad Sci USA 1996 93: 1054–1059

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  18. Yamamoto K, Arakawa T, Ueda N, Yamamoto S . Transcriptional roles of nuclear factor κB and nuclear factor-interleukin-6 in the tumor necrosis factor α-dependent induction of cyclooxygenase-2 in MC3T3-E1 cells J Biol Chem 1995 270: 31315–31320

    Article  CAS  PubMed  Google Scholar 

  19. Xie Q, Kashiwabara Y, Nathan C . Role of transcription factor NF-κB/Rel in induction of nitric oxide J Biol Chem 1994 269: 4705–4708

    CAS  PubMed  Google Scholar 

  20. Thanos D, Maniatis T . NF-κB: a lesson in family values Cell 1995 80: 529–532

    Article  CAS  PubMed  Google Scholar 

  21. Baeuerle PA, Baltimore D . NF-κB: ten years after Cell 1996 87: 13–20

    Article  CAS  PubMed  Google Scholar 

  22. Baldwin AS Jr . The NF-κB and IκB proteins: new discoveries and insights Ann Rev Immunol 1996 14: 649–681

    Article  Google Scholar 

  23. Finco TS, Baldwin AS . Mechanistic aspects of NF-κB regulation: the emerging role of phosphprylation and proteolysis Immunity 1995 3: 263–272

    Article  CAS  PubMed  Google Scholar 

  24. Baeuerle PA, Henkel T . Function and activation of NF-κB in the immune system Ann Rev Immunol 1994 12: 141–179

    Article  CAS  Google Scholar 

  25. May MJ, Ghosh S . Signal transduction through NF-κB Immunol Today 1998 19: 80–88

    Article  CAS  PubMed  Google Scholar 

  26. Schreck R et al. Dithiocarbamate as potent inhibitors of nuclear factor κB activation in intact cells J Exp Med 1992 175: 1181–1194

    Article  CAS  PubMed  Google Scholar 

  27. D'Acquisto F et al. Activation of nuclear transcription factor κB in rat carrageenin-induced pleurisy Eur J Pharmacol 1999 369: 233–236

    Article  CAS  PubMed  Google Scholar 

  28. D'Acquisto F, Ialenti A, Ianaro A, Carnuccio R . Nuclear factor-kB mediates inducible nitric oxide synthase protein expression in carrageenin-induced rat pleurisy N-S Arch Pharmacol 1999 360: 670–675

    Article  CAS  Google Scholar 

  29. Pierce JW et al. Novel inhibitor of cytokine-induced IκBα phorphorylation and endothelial cell adhesion molecule expression show anti-inflammatory effects in vivo J Biol Chem 1997 272: 21096–21103

    Article  CAS  PubMed  Google Scholar 

  30. Bielinska A, Schivdasani RA, Zhang L, Nabel GJ . Regulation of gene expression with double stranded phosphorothioate oligonucleotides Science 1990 250: 997–1000

    Article  CAS  PubMed  Google Scholar 

  31. Morishita R et al. In vivo transfection of cis element ‘decoy’ against nuclear factor-κB site prevents myocardial infarction Nature Med 1997 8: 894–899

    Article  Google Scholar 

  32. Kawamura I et al. Intratumoral injection of oligonucleotides to the NF-κB binding site inhibits cachexia in a mouse tumor model Gene Therapy 1999 6: 91–97

    Article  CAS  PubMed  Google Scholar 

  33. Sharma HW et al. Transcription factor decoy approach to decipher the role of NF-κB in oncogenesis Anticancer Res 1996 16: 61–70

    CAS  PubMed  Google Scholar 

  34. Schmedtje JF Jr et al. Hypoxia induces cyclooxygenase-2 via the NF-κB p65 transcription factor in human vascular endothelial cells J Biol Chem 1997 272: 601–608

    Article  PubMed  Google Scholar 

  35. Roshak AK et al. Manipulation of distinct NF-κB proteins alters interleukin-1β-induced human rheumatoid synovial fibroblast prostaglandin E2 formation J Biol Chem 1996 271: 31496–31501

    Article  CAS  PubMed  Google Scholar 

  36. Lin YZ et al. Inhibition of nuclear translocation of transcription factor NF-kappa B by a synthetic peptide containing a cell membrane-permeable motif and nuclear localisation sequence J Biol Chem 1995 270: 14255–14258

    Article  CAS  PubMed  Google Scholar 

  37. Morishita R et al. A gene therapy strategy using a transcription factor decoy of the E2F binding site inhibits smooth muscle proliferation in vivo Proc Natl Acad Sci USA 1995 92: 5855–5859

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  38. Miagkov AV et al. NF-κB activation provides the potential link between inflammation and hyperplasia in arthritic joint Proc Natl Acad Sci USA 1998 95: 13859–13864

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  39. Tomita T et al. Suppressed severity of collagen-induced arthritis by in vivo transfection of nuclear factor kappaB decoy oligodeoxynucleotides as a gene therapy Arthr Rheum 1999 42: 2532–2542

    Article  CAS  Google Scholar 

  40. Di Rosa M, Willoughby DA . Screens for anti-inflammatory drugs J Pharm Pharmacol 1971 23: 297–298

    Article  CAS  PubMed  Google Scholar 

  41. Kopp E, Ghosh S . Inhibition of NF-κB by sodium salicylate and aspirin Science 1994 265: 956–959

    Article  CAS  PubMed  Google Scholar 

  42. Auphan N et al. Immunosuppression by glucocorticoids: inhibition of NF-κB activity trough induction of IκB synthesis Science 1995 270: 286–290

    Article  CAS  PubMed  Google Scholar 

  43. Scheiman R, Cogwell P, Lofquist A, Baldwin A . Role of transcriptional activation of IκBα in mediation of immunosuppression by glucocorticoids Science 1995 270: 283–286

    Article  Google Scholar 

  44. Adcock IM, Newton R, Barnes PJ . NF-kappa B involvement in IL-1 beta-induction of GM-CSF and COX-2: inhibition by glucocorticoids does not require I-kappa B Biochem Soc Trans 1997 25: 154S

    Article  CAS  PubMed  Google Scholar 

  45. Fernandez de Arriba A et al. Inhibition of cyclooxygenase-2 expression by 4-trifluoromethyl derivates of salicylate, triflusal, and its deacetylated metabolite, 2-hydroxy-4-trifluoromethylbenzoic acid Mol Pharmacol 1999 55: 753–760

    CAS  PubMed  Google Scholar 

  46. De Vera ME et al. Dexamethasone suppresses iNOS gene expression by upregulating I-kappa B alpha and inhibiting NF-kappa B Am J Physiol 1997 273: G1290–G1296

    Article  CAS  PubMed  Google Scholar 

  47. Bayon Y, Alonso A, Sanchez Crespo M . 4-trifluoromethyl derivatives and its main metabolite 2-hydroxy-4-trifluoromethylbenzoic acid, are potent inhibitors of nuclear factor kappa B activation Br J Pharmacol 1999 126: 1359–1366

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  48. Goldring CEP, Narayaznan R, Lagadec P, Jeannin JF . Transcriptional inhibition of the inducible nitric oxide synthase gene by competitive binding of NF-κB/Rel proteins Biochem Biophys Res Comm 1995 209: 73–79

    Article  CAS  PubMed  Google Scholar 

  49. Morris CJ, Earl JR, Tenam CW, Blame DR . Reactive oxygen species and iron – a dangerous partnership in inflammation Int J Biochem Cell Biol 1995 27: 109–122

    Article  CAS  PubMed  Google Scholar 

  50. Schmidt KN, Amstad P, Cerruti P, Baeuerle PA . The roles of hydrogen peroxide and superoxide as messenger in the activation of transcription factor NF-κB Chem Biol 1995 2: 13–22

    Article  CAS  PubMed  Google Scholar 

  51. Sakurada S, Kato T, Okamoto T . Induction of cytokines and ICAM-1 by proinflammatory cytokines in primary rheumatoid synovial fibroblast and inhibition by N-acetyl-L-cysteine and aspirin Int Immunol 1996 8: 1483–1493

    Article  CAS  PubMed  Google Scholar 

  52. Sakurai H et al. Activation of transcription factor NF-κB in experimental glomerulonephitis in rats Biochem Biophys Acta 1996 1316: 132–138

    PubMed  Google Scholar 

  53. D'Acquisto F et al. Inhibition of nuclear factor-κB prevents the loss of vascular tone in lipopolysaccharide-treated rats Eur J Pharmacol 1999 365: 253–257

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgements

This work was supported in part by MURST 40% and 60% research grant 1997 and 1998.

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

D'Acquisto, F., Ialenti, A., Ianaro, A. et al. Local administration of transcription factor decoy oligonucleotides to nuclear factor-κB prevents carrageenin-induced inflammation in rat hind paw. Gene Ther 7, 1731–1737 (2000). https://doi.org/10.1038/sj.gt.3301295

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.gt.3301295

Keywords

This article is cited by

Search

Quick links